Article | May 20, 2020

Improving The Patient Experience Without Sacrificing Quality Of Care


Oncology drugs have rapidly evolved, but the delivery technology has not changed as quickly. While intravenous-based (IV) therapies are effective, they require patients to spend hours in an infusion center. In an effort to change how IV- and syringe-based oncology drug treatments are administered, West’s SmartDose® platform is available to expand patient access to SC delivery via a large-volume device that attaches to the patient. This gives the patient more freedom of movement at the center or allows administration to occur at a different location altogether.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Med Device Online? Subscribe today.

Subscribe to Med Device Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Med Device Online

West Pharmaceutical Services, Inc.